Literature DB >> 20586640

Pseudoangiomatous stromal hyperplasia: an overview.

Renu K Virk1, Ashraf Khan.   

Abstract

Pseudoangiomatous stromal hyperplasia (PASH) of the breast is a benign, proliferative mesenchymal lesion with possible hormonal etiology. It typically affects women in the reproductive age group. Pseudoangiomatous stromal hyperplasia is frequently an incidental histologic finding in breast biopsies performed for other benign or malignant lesions. Rarely, it can present as a firm, painless breast mass, which has been referred to as nodular or tumorous PASH. Grossly, tumorous PASH is a well-circumscribed, firm, rubbery mass with solid, homogenous, gray-white cut surface. On histologic examination, it is characterized by the presence of open slitlike spaces in dense collagenous stroma. The spaces are lined by a discontinuous layer of flat, spindle-shaped myofibroblasts with bland nuclei. The spindle cells express progesterone receptors and are positive for vimentin, actin, and CD34. The most important differential diagnosis on histopathology is angiosarcoma. Pseudoangiomatous stromal hyperplasia discovered incidentally does not require any additional specific treatment. Tumorous PASH is treated by local surgical excision with clear margins and the prognosis is excellent, with minimal risk of recurrence after adequate surgical excision.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20586640     DOI: 10.5858/2008-0686-RS.1

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  25 in total

Review 1.  Benign Breast Disease in Women.

Authors:  Angrit Stachs; Johannes Stubert; Toralf Reimer; Steffi Hartmann
Journal:  Dtsch Arztebl Int       Date:  2019-08-09       Impact factor: 5.594

2.  Giant pseudoangiomatous stromal hyperplasia presenting in the breast of a prepubertal child.

Authors:  Tarig Abdelrahman; Philippa Young; Olexandra Kozyar; Eleri Davies; Stefan Dojcinov; Robert E Mansel
Journal:  BMJ Case Rep       Date:  2015-05-22

3.  Bilateral Diffuse Pseudoangiomatous Stromal Hyperplasia (PASH) Causing Gigantomastia in a 33-Year-Old Pregnant Woman: Case Report.

Authors:  Natalia Krawczyk; Tanja Fehm; Eugen Ruckhäberle; Svjetlana Mohrmann; Jasmin Riemer; Stefan Braunstein; Jürgen Hoffmann
Journal:  Breast Care (Basel)       Date:  2016-10-24       Impact factor: 2.860

4.  Pseudoangiomatous stromal hyperplasia causing massive breast enlargement.

Authors:  Anita Geraldine Bourke; Stephen Tiang; Nathan Harvey; Robert McClure
Journal:  BMJ Case Rep       Date:  2015-10-16

5.  Treatment of Pseudoangiomatous Stromal Hyperplasia of the Breast: Implant-Based Reconstruction with a Vascularized Dermal Sling.

Authors:  Bok Ki Jung; Ji Hae Nahm; Dae Hyun Lew; Dong Won Lee
Journal:  Arch Plast Surg       Date:  2015-09-15

6.  Nodule-Forming Pseudoangiomatous Stromal Hyperplasia of the Breast: Report of Three Cases.

Authors:  Canan Kelten; Ceren Boyaci; Cem Leblebici; Mehmet Ali Nazli; Şefika Aksoy; Didem Can Trabulus; Erol Rüştü Bozkurt
Journal:  J Breast Health       Date:  2015-07-01

7.  Inflammatory Myofibroblastic Tumor of the Breast Coexisting with Pseudoangiomatous Stromal Hyperplasia.

Authors:  Canan Kelten Talu; Yasemin Çakır; Ezgi Hacıhasanoğlu; Cem Leblebici; Şefika Aksoy; Mehmet Ali Nazlı
Journal:  J Breast Health       Date:  2016-10-01

8.  Bilateral pseudoangiomatous stromal hyperplasia tumors in axillary male gynecomastia: report of a case.

Authors:  Roger M Vega; David Pechman; Burco Ergonul; Carmen Gomez; Mecker G Moller
Journal:  Surg Today       Date:  2014-03-28       Impact factor: 2.549

9.  Pseudoangiomatous stromal hyperplasia (PASH) tumour at the surgical scar site in a patient of carcinoma breast.

Authors:  Andleeb Abrari
Journal:  BMJ Case Rep       Date:  2011-08-11

10.  Recruitment of CD34(+) fibroblasts in tumor-associated reactive stroma: the reactive microvasculature hypothesis.

Authors:  Rebeca San Martin; David A Barron; Jennifer A Tuxhorn; Steven J Ressler; Simon W Hayward; Xiaoyun Shen; Rodolfo Laucirica; Thomas M Wheeler; Carolina Gutierrez; Gustavo E Ayala; Michael Ittmann; David R Rowley
Journal:  Am J Pathol       Date:  2014-04-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.